Literature DB >> 31900080

The effect of vitamin D and calcium supplementation on inflammatory biomarkers, estradiol levels and severity of symptoms in women with postpartum depression: a randomized double-blind clinical trial.

Shirin Amini1,2, Reza Amani3, Sima Jafarirad1,4, Bahman Cheraghian5, Mehdi Sayyah6, Ali Asghar Hemmati7.   

Abstract

Objectives: Postpartum depression (PPD) is a major depressive disorder. Vitamin D deficiency may play a role in PPD pathogenesis. This study was designed to determine the effect of vitamin D and calcium supplementation on the severity of symptoms and some related inflammatory biomarkers in women with PPD.Materials and
Methods: Eighty-one women with a PPD score >12 participated in this study. A total of 27 patients were randomly assigned into three groups (1:1:1 ratio) to receive either 50,000 IU vitamin D3 fortnightly + 500 mg calcium carbonate daily; or 50,000 IU vitamin D3 fortnightly + placebo of calcium carbonate daily, or placebo of vitamin D3 fortnightly + placebo of calcium carbonate daily (placebo group) for 8 weeks. At the baseline and end of the study, the severity score of PPD, levels of 25-hydroxy vitamin D, calcium, tumor necrosis factor-alpha (TNFα), interleukin 6 (IL6) and estradiol were measured.
Results: The PPD score had more reduction in the vitamin D + calcium and vitamin D + calcium placebo groups than that of the placebo group (-1.7 ± 3.44, -4.16 ± 5.90 and 0.25 ± 2.81, respectively; p = 0.008). The effect of vitamin D on the PPD score was larger when vitamin D was given alone than given together with calcium (p = 0.042 and p = 0.004, respectively). No significant differences in estradiol, IL6 and TNFα were observed between the three groups.Discussion: Vitamin D may be effective in improving the clinical symptoms of PPD; however, the mechanism of the effect might not entirely operate through inflammatory and/or hormonal changes.

Entities:  

Keywords:  Vitamin D; depression; estradiol; high sensitive C-reactive protein; inflammatory mediators; interleukin 6; postpartum; tumor necrosis factor-alpha

Mesh:

Substances:

Year:  2020        PMID: 31900080     DOI: 10.1080/1028415X.2019.1707396

Source DB:  PubMed          Journal:  Nutr Neurosci        ISSN: 1028-415X            Impact factor:   4.994


  6 in total

1.  Is Vitamin D Status Associated with Depression, Anxiety and Sleep Quality in Pregnancy: A Systematic Review.

Authors:  Melika Fallah; Gholamreza Askari; Zatollah Asemi
Journal:  Adv Biomed Res       Date:  2020-07-27

Review 2.  A Systematic Review of Vitamin D during Pregnancy and Postnatally and Symptoms of Depression in the Antenatal and Postpartum Period from Randomized Controlled Trials and Observational Studies.

Authors:  Jacqueline F Gould; Robert A Gibson; Tim J Green; Maria Makrides
Journal:  Nutrients       Date:  2022-05-30       Impact factor: 6.706

3.  PPAR and functional foods: Rationale for natural neurosteroid-based interventions for postpartum depression.

Authors:  Francesco Matrisciano; Graziano Pinna
Journal:  Neurobiol Stress       Date:  2020-04-19

Review 4.  The Problem of Malnutrition Associated with Major Depressive Disorder from a Sex-Gender Perspective.

Authors:  Cielo García-Montero; Miguel A Ortega; Miguel Angel Alvarez-Mon; Oscar Fraile-Martinez; Adoración Romero-Bazán; Guillermo Lahera; José Manuel Montes-Rodríguez; Rosa M Molina-Ruiz; Fernando Mora; Roberto Rodriguez-Jimenez; Javier Quintero; Melchor Álvarez-Mon
Journal:  Nutrients       Date:  2022-03-06       Impact factor: 5.717

Review 5.  Effect of vitamin D supplementation on the incidence and prognosis of depression: An updated meta-analysis based on randomized controlled trials.

Authors:  Fei Xie; Tongmin Huang; Dandi Lou; Rongrong Fu; Chaoxiong Ni; Jiaze Hong; Lingyan Ruan
Journal:  Front Public Health       Date:  2022-08-01

6.  The Efficacy of Calcium Carbonate-Vitamin D3 in Pregnant Women for the Prevention of Hypertensive Disorders in Pregnancy.

Authors:  Zhen Chen; Jing Chen
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-11       Impact factor: 2.650

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.